BG Medicine Inc
OTC:BGMD
BG Medicine Inc
Revenue
BG Medicine Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BG Medicine Inc
OTC:BGMD
|
Revenue
$1.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is BG Medicine Inc's Revenue?
Revenue
1.6m
USD
Based on the financial report for Dec 31, 2015, BG Medicine Inc's Revenue amounts to 1.6m USD.
What is BG Medicine Inc's Revenue growth rate?
Revenue CAGR 5Y
14%
Over the last year, the Revenue growth was -44%. The average annual Revenue growth rates for BG Medicine Inc have been -18% over the past three years , 14% over the past five years .